OSCR

<i>FAM122B</i> acts as an independent poor prognostic factor and promotes the malignant biological behaviors of low-grade glioma.

Overview

Authors: Hao Wang1,2, Tengfei Guo2, Yanbo Gao2, Yi Zhou1, Rongjun Qian2
  1. The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, Henan 450003, P.R. China
  2. Department of Neurosurgery, Henan Provincial People's Hospital, Zhengzhou, Henan 450003, P.R. China
Institutions: First Affiliated Hospital of Henan University of Traditional Chinese Medicine (China); Henan Provincial People's Hospital (China)
Journal: Oncology letters, volume 32, issue 4, article 427
Dates: received 25 February 2026; accepted 16 June 2026; published online 28 July 2026
Type: Research article · Language: English
License: CC BY-NC-ND
Identifiers: DOI 10.3892/ol.2026.15782 · PMID 42577600 · PMCID PMC13454829 · OpenAlex W7171589676
Open access: diamond, a free copy (OpenAlex)
Status: data only
Categories: other condition (population), clinical / translational (subfield)
Methods: Statistics, Connectivity
Keywords: low-grade glioma, FAM122B, prognostic biomarker, oncogene, cell proliferation
Topic: Glioma Diagnosis and Treatment (Genetics, Medicine), according to OpenAlex
Funding: Henan Provincial Key Research and Development Program (251111312600); Henan Young and Middle-aged Health Science and Technology Innovation Talent Project (LJRC2023007)
Citations: not cited yet (Europe PMC); 54 references in the paper

Abstract

The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.

Code

The paper links to its data, not to its authors' code: see the Data section.

Tracing map

A tracing map links a paper to the code its authors published: this paper has none, so it has no map.

Data

Data links

Data availability statement

The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:

  • no repository, dataset or request procedure was recognized in it

Read it in the paper: doi.org/10.3892/ol.2026.15782.

Versions

The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.

Version 1, 27 September 2026: the first record

Recorded: type, language, journal, volume, issue, pages, dates, 5 authors, 5 keywords, 2 funders, 54 references.

Cite

This paper

Wang, H., Guo, T., Gao, Y., Zhou, Y., & Qian, R. (2026). <i>FAM122B</i> acts as an independent poor prognostic factor and promotes the malignant biological behaviors of low-grade glioma. Oncology letters, 32(4), 427. https://doi.org/10.3892/ol.2026.15782

BibTeX

@article{wang2026lt,
author = {Wang, Hao and Guo, Tengfei and Gao, Yanbo and Zhou, Yi and Qian, Rongjun},
title = {{\<i\>FAM122B\</i\> acts as an independent poor prognostic factor and promotes the malignant biological behaviors of low-grade glioma}},
journal = {Oncology letters},
year = {2026},
month = jul,
volume = {32},
number = {4},
pages = {427},
publisher = {Spandidos Publications},
issn = {1792-1074},
doi = {10.3892/ol.2026.15782},
url = {https://doi.org/10.3892/ol.2026.15782},
pmid = {42577600},
pmcid = {PMC13454829}
}

RIS

TY - JOUR
AU - Wang, Hao
AU - Guo, Tengfei
AU - Gao, Yanbo
AU - Zhou, Yi
AU - Qian, Rongjun
TI - <i>FAM122B</i> acts as an independent poor prognostic factor and promotes the malignant biological behaviors of low-grade glioma
T2 - Oncology letters
J2 - Oncol Lett
PY - 2026
DA - 2026/07/28
VL - 32
IS - 4
SP - 427
SN - 1792-1074
PB - Spandidos Publications
DO - 10.3892/ol.2026.15782
UR - https://doi.org/10.3892/ol.2026.15782
LA - en
ER -

CSL-JSON

{
"id": "10.3892/ol.2026.15782",
"type": "article-journal",
"title": "<i>FAM122B</i> acts as an independent poor prognostic factor and promotes the malignant biological behaviors of low-grade glioma",
"container-title": "Oncology letters",
"author": [
{
"family": "Wang",
"given": "Hao"
},
{
"family": "Guo",
"given": "Tengfei"
},
{
"family": "Gao",
"given": "Yanbo"
},
{
"family": "Zhou",
"given": "Yi"
},
{
"family": "Qian",
"given": "Rongjun"
}
],
"container-title-short": "Oncol Lett",
"volume": "32",
"issue": "4",
"page": "427",
"DOI": "10.3892/ol.2026.15782",
"PMID": "42577600",
"PMCID": "PMC13454829",
"ISSN": "1792-1074",
"publisher": "Spandidos Publications",
"URL": "https://doi.org/10.3892/ol.2026.15782",
"language": "en",
"issued": {
"date-parts": [
[
2026,
7,
28
]
]
}
}

Similar papers

The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.

[1] doi:10.1038/s41746-026-02695-2 [code]
Comparing artificial intelligence and physician performance in predicting IDH mutation status in glioma.
Journal: NPJ digital medicine
In common: other condition, 2 references
[2] doi:10.1111/bpa.70125
From patient to tumor organoid: Culture protocol choice controls glioblastoma tumor architecture and identity.
Journal: Brain pathology (Zurich, Switzerland)
In common: clinical / translational, other condition, 1 reference
[3] doi:10.3390/ijms27167240
1-Piperidine Propionic Acid Inhibits PAR2/SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness.
Journal: International journal of molecular sciences
In common: other condition, 2 references
[4] doi:10.3892/ijmm.2026.5912
<i>FLI1</i> enhances the malignant phenotype of glioma cells and exerts immunomodulatory effects through feedback crosstalk with exonic circRNA <i>FECR1</i> and interferon‑induced <i>ISG15</i>.
Journal: International journal of molecular medicine
In common: other condition, 2 references
[5] doi:10.1007/s12672-026-05414-1
Construction and validation of a model based on necroptosis-related genes for predicting glioma prognosis.
Journal: Discover oncology
In common: other condition, 1 reference
[6] doi:10.1002/adhm.202504842
Flash Assembloids: A Rapid Biofabrication of a Platform for Modeling Early Glioblastoma Invasion at the Glioblastoma-Brain Organoid Interfaces.
Journal: Advanced healthcare materials
In common: other condition, 1 reference
[7] doi:10.3389/fonc.2026.1771697
EMILIN-1 in the tumor microenvironment: insights from CNS tumors and beyond.
Journal: Frontiers in oncology
In common: other condition, 1 reference
[8] doi:10.1038/s41591-026-04547-8
Immunotherapy with a short-lived anti-PD-L1 antibody in Alzheimer's disease: a phase 1b, randomized, double-blind trial.
Journal: Nature medicine
In common: clinical / translational, 1 reference
[9] doi:10.1038/s41591-026-04497-1 [code]
Health system learning enables generalist neuroimaging models.
Journal: Nature medicine
In common: clinical / translational, 1 reference
[10] doi:10.1111/jon.70146
Pitfalls in 2HG Detection With TE-Optimized MRS at 3T.
Journal: Journal of neuroimaging : official journal of the American Society of Neuroimaging
In common: clinical / translational, other condition, 1 reference

Contribute

The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.

Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.

Request its removal

To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).

Discussion, reproductions, activity

Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.

Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.

Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.